Angiotensin type 1 and type 2 receptors during ontogeny: Cardiovascular and renal effects

Vascular Pharmacology

Volumn 63, Issue 3, 2014, Pages 145-154

  Vinturache, Angela Elena ^a,b   Smith, Francine Gabriel ^a,b  

^a ALBERTA CHILDREN S HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Angiotensin receptor; Cardiovascular; Development; Kidney; Newborn

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

CARDIOVASCULAR SYSTEM; HEMODYNAMICS; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; NONHUMAN; ONTOGENY; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL ONTOLOGY; KIDNEY; METABOLISM; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; BIOLOGICAL ONTOLOGIES; CARDIOVASCULAR SYSTEM; HUMANS; KIDNEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84918780975     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2014.11.001     Document Type: Review

References (136)

1. AbdAlla S., Lother H., Abdel-awab A.M., Quitterer U. The angiotensin II AT 2 receptor is an AT 1 receptor antagonist. J Biol Chem 2001, 276:39721-39726.
2. Aguilera G., Kapur S., Feuillan P., Sunar-Akbasak B., Bathia A.J. Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int 1994, 46:973-979.
3. Alexander B.T. Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1-R10.
4. Alwan S., Polifka J.E., Friedman J.M. Addendum: sartan treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005, 73:904-905.
5. Alwan S., Polifka J.E., Friedman J.M. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005, 73:123-130.
6. Bagby S.P. Angiotensin II type 1 and 2 receptors in conduit arteries of normal developing microswine. Arterioscler Thromb Vasc Biol 2002, 22:1113-1121.
7. Bagby S.P., LeBard L.S., Luo Z., Ogden B.E., Corless C.L., McPherson E.D., et al. ANG II AT1 and AT2 receptors in developing kidney of normal microswine. Am J Physiol Renal Physiol 2002, 283:F755-F764.
8. Bagby S.P., LeBard L.S., Luo Z., Speth R.C., Ogden B.E., Corless C.L. Angiotensin II type 1 and 2 receptors in conduit arteries of normal developing swine. Arterioscler Thromb Vasc Biol 2002, 22:1113-1121.
9. Batenburg W.W., Tom B., Schuijt M.P., Danser A.H. Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vasc Pharmacol 2005, 42:109-118.
10. Berry C., Touyz R., Dominiczak A.F., Webb R.C., Johns D.G. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001, 281:H2337-H2365.
11. Bottari S.P., de Gasparo M., Steckelings M., Levens N.R. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol 1993, 14(2):123-171.
12. Butkus A., Albiston A., Alcorn D., Giles M., McCausland J., Moritz K., et al. Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros. Kidney Int 1997, 51:628-636.
13. Carey R.M. Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens 2005, 14:67-71.
14. Carey R.M., Jin X.H., Wang Z.Q., Siragy H.M. Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 2000, 168:65-71.
15. Carey R.M., Padia S.H. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab 2008, 19:84-87.
16. Carey R.M., Wang Z.Q., Siragy H.M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 2000, 35:155-173.
17. Chappellaz M.L., Smith F.G. Dose-dependent systemic and renal haemodynamic effects of angiotensin II in conscious lambs: role of angiotensin AT1 and AT2 receptors. Exp Physiol 2005, 90:837-845.
18. Chappellaz M.L., Smith F.G. Systemic and renal hemodynamic effects of the AT 1 receptor antagonist, ZD 7155, and the AT 2 receptor antagonist, PD 123319, in conscious lambs. Pflugers Arch - Eur J Physiol 2007, 453:477-486.
19. Chen Y., Lasaitiene D., Friberg P. The renin-angiotensin system in kidney development. Acta Physiol Scand 2004, 181:529-535.
20. Chen Y., Lasaitiene D., Gabrielsson B.G., Carlsson L.M., Billig H., Carlsson B., et al. Neonatal losartan treatment suppresses renal expression of molecules involved in cell-cell and cell-matrix interactions. J Am Soc Nephrol 2004, 15:1232-1243.
21. Chevalier R.L., Thornhill B.A., Belmonte D.C., Baertschi A.J. Endogenous angiotensin II inhibits natriuresis after acute volume expansion in the neonatal rat. Am J Physiol 1996, 270:R393-R397.
22. Corvol P., Schutz S., Gasc J.M. Early expression of all components of the renin-angiotensin system in human development. Adv Nephrol Necker Hosp 1998, 28:195-212.
23. Cox B.E., Liu X.T., Fluharty S.J., Rosenfeld C.R. Vessel-specific regulation of angiotensin II receptor subtypes during ovine development. Pediatr Res 2005, 57:124-132.
24. Cox B.E., Rosenfeld C.R. Ontogeny of vascular angiotensin II receptor subtype expression in ovine development. Pediatr Res 1999, 45:414-424.
25. Davidson D. Circulating vasoactive substances and hemodynamic adjustments at birth in lambs. J Appl Physiol 1987, 63:676-684.
26. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
27. de Gasparo M., Siragy H.M. The AT 2 receptor: fact, fancy and fantasy. Regul Pept 2005, 81:11-24.
28. de Wildt S.N., Smith F.G. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine and renal responses to furosemide in conscious lambs. Can J Physiol Pharmacol 1997, 75:263-270.
29. Dinh D.T., Frauman A.G., Johnston C.I., Fabiani M.E. Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) 2001, 100:481-492.
30. Drukker A., Goldsmith D.I., Spitzer A., Edelmann C.M., Blaufox M.D. The renin angiotensin system in newborn dogs: developmental patterns and response to acute saline loading. Pediatr Res 1980, 14:304-307.
31. Elton T.S., Martin M.M. Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor. Trends Endocrinol Metab 2003, 14(2):66-71.
32. Endo A., Ayusawa M., Minato M., Takada M., Takahashi S., Harada K. Endothelium-derived relaxing and contracting factors during the early neonatal period. Acta Paediatr 1997, 86:834-836.
33. Friberg P., Sundelin B., Bohman S.O., Bobik A., Nilsson H., Wickman A., et al. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 1994, 45:485-492.
34. Garcia-Villalba P., Denkers N.D., Wittwer C.T., Hoff C., Nelson R.D., Mauch T.J. Real-time PCR quantification of AT1 and AT2 angiotensin receptor mRNA expression in the developing rat kidney. Nephron Exp Nephrol 2003, 94:e154-e159.
35. Gasc J.M., Shanmugam S., Sibony M., Corvol P. Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 1994, 24:531-537.
36. Gimonet V., Bussieres L., Medjebeur A.A., Gasser B., Lelongt B., Laborde K. Nephrogenesis and angiotensin II receptor subtypes gene expression in the fetal lamb. Am J Physiol 1998, 274:F1062-F1069.
37. Grady E.F., Sechi L.A., Griffin C.A., Schambelan M., Kalinyak J.E. Expression of AT 2 receptors in the developing rat fetus. J Clin Invest 1991, 88:921-933.
38. Granger P., Rojo-Ortega J.M., Perez S.C., Boucher R., Genest J. The renin-angiotensin system in newborn dogs. Can J Physiol Pharmacol 1971, 49:134-138.
39. Griendling K.K., Alexander R.W. The angiotensin (AT1) receptor. Semin Nephrol 1993, 13:558-566.
40. Griendling K.K., Lassegue B., Alexander R.W. The vascular angiotensin (AT1) receptor. Thromb Haemost 1993, 70:188-192.
41. Gruskin A.B., Edelmann J.C.M., Yuan S. Maturational changes in renal blood flow in piglets. Pediatr Res 1970, 4:7-13.
42. Gubler M.C., Antignac C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int 2010, 77:400-406.
43. Guignard J.P. Renal function in the newborn infant. Pediatr Clin N Am 1982, 29:777-790.
44. Guron G. Renal haemodynamics and function in weanling rats treated with enalapril from birth. Clin Exp Pharmacol Physiol 2005, 32:865-870.
45. Guron G., Nilsson A., Leyssac P.P., Sundelin B., Friberg P. Proximal tubular function in adult rats treated neonatally with enalapril. Acta Physiol Scand 1998, 164:99-106.
46. Guron G., Nilsson A., Nitescu N., Nielsen S., Sundelin B., Frokiaer J., et al. Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril. Acta Physiol Scand 1999, 165:103-112.
47. Guron G., Sundelin B., Wickman A., Friberg P. Angiotensin-converting enzyme inhibition in piglets induces persistent renal abnormalities. Clin Exp Pharmacol Physiol 1998, 25:88-91.
48. Gwathmey T.M., Shaltout H.A., Pendergrass K.D., Pirro N.T., Figueroa J.P., Rose J.C., et al. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol 2009, 296:F1484-F1493.
49. Hansen J.L., Servant G., Baranski T.J., Fujita T., Iiri T., Sheikh S.P. Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. Circ Res 2000, 87:753-759.
50. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995, 377:744-747.
51. Heymann M.A., Iwamoto H.S., Rudolph A.M. Factors affecting changes in the neonatal systemic circulation. Annu Rev Physiol 1981, 43:371-383.
52. Hu F., Morrissey P., Yao J., Xu Z. Development of AT(1) and AT(2) receptors in the ovine fetal brain. Brain Res Dev Brain Res 2004, 150:51-61.
53. Huet F., Semama D.S., Gouyon J.B., Guignard J.P. Protective effect of perindoprilat in the hypoxemia-induced renal dysfunction in the newborn rabbit. Pediatr Res 1999, 45:138-142.
54. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A., et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995, 377:748-750.
55. Jin X.Q., Fukuda N., Su J.Z., Lai Y.M., Suzuki R., Tahira Y., et al. Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 2002, 39:1021-1027.
56. Jones E.S., Vinh A., McCarthy C.A., Gaspari T.A., Widdop R.E. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008, 120:292-316.
57. Kakuchi J., Ichiki T., Kiyama S., Hogan B.L., Fogo A., Inagami T., et al. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995, 47:140-147.
58. Kaschina E., Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003, 12:70-88.
59. Kleinman L.I. Renal sodium reabsorption during saline loading and distal blockade in newborn dogs. Am J Physiol 1975, 228:1403-1407.
60. Lacoste M., Cai Y., Guicharnaud L., Mounier F., Dumez Y., Bouvier R., et al. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol 2006, 17:2253-2263.
61. Lumbers E.R., Burrell J.H., Menzies R.I., Stevens A.D. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function. Brit J Pharmacol 1993, 110:821-827.
62. Mao C., Shi L., Xu F., Zhang L., Xu Z. Development of fetal brain renin-angiotensin system and hypertension programmed in fetal origins. Prog Neurobiol 2009, 87:252-263.
63. Marrero M.B., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 375:247-250.
64. Matsubara H., Kanasaki M., Murasawa S., Tsukaguchi Y., Nio Y., Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994, 93:1592-1601.
65. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97.
66. Monument M.J., Smith F.G. Age-dependent effects of captopril on the arterial baroreflex control of heart rate in conscious lambs. Exp Physiol 2003, 88:761-768.
67. Moore A.F., Heiderstadt N.T., Huang E., Howell N.L., Wang Z.Q., Siragy H.M., et al. Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension 2001, 37:1285-1291.
68. Mottl A.K., Shoham D.A., North K.E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008, 10(8):560-574.
69. Nakajima M., Hutchinson H.G., Fujinaga M., Hayashida W., Morishita R., Zhang L., et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995, 92:10663-10667.
70. Nakamura K.T., Matherne G.P., McWeeny O.J., Smith B.A., Robillard J.E. Renal hemodynamics and functional changes during the transition from fetal to newborn life in sheep. Pediatr Res 1987, 21:229-234.
71. Nishimura H., Yerkes E., Hohenfellner K., Miyazaki Y., Ma J., Hunley T.E., et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999, 3:1-10.
72. Nouet S., Nahmias C. Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab 2000, 11:1-6.
73. Oliverio M.I., Best C.F., Kim H.S., Arendshorst W.J., Smithies O., Coffman T.M. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am J Physiol 1997, 272:F515-F520.
74. Oshima K., Miyazaki Y., Brock J.W., Adams M.C., Ichikawa I., Pope J.C. Angiotensin type II receptor expression and ureteral budding. J Urol 2001, 166:1848-1852.
75. Padia S.H., Howell N.L., Siragy H.M., Carey R.M. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006, 47:537-544.
76. Patzak A., Persson A.E. Angiotensin II-nitric oxide interaction in the kidney. Curr Opin Nephrol Hypertens 2007, 16:46-51.
77. Paul M., Poyan M.A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.
78. Pinaud F., Bocquet A., Dumont O., Retailleau K., Baufreton C., Andriantsitohaina R., et al. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007, 50:96-102.
79. Porrello E.R., Delbridge L.M., Thomas W.G. The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci 2009, 14:958-972.
80. Prevot A., Mosig D., Guignard J.P. The effects of losartan on renal function in the newborn rabbit. Pediatr Res 2002, 51:728-732.
81. Qi W., Vinturache A.E., Smith F.G. Cardiovascular and renal effects of angiotensin II type 2 receptors (AT2R) during ontogeny. Curr Top Pharmacol 2011, 15:1-16.
82. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006, 82:23-28.
83. Ratliff B., Rodebaugh J., Sekulic M., Dong K.W., Solhaug M. Nitric oxide synthase and renin-angiotensin gene expression and NOS function in the postnatal renal resistance vasculature. Pediatr Nephrol 2009, 24:355-365.
84. Ratliff B., Rodebaugh J., Sekulic M., Solhaug M. Glomerular eNOS gene expression during postnatal maturation and AT1 receptor inhibition. Pediatr Nephrol 2007, 22:1135-1142.
85. Ratliff B.B., Sekulic M., Rodebaugh J., Solhaug M.J. Angiotensin II regulates NOS expression in afferent arterioles of the developing porcine kidney. Pediatr Res 2010, 68:29-34.
86. Robillard J.E., Schutte B.C., Page W.V., Fedderson J.A., Porter C.C., Segar J.L. Ontogenic changes and regulation of renal angiotensin II type 1 receptor gene expression during fetal and newborn life. Pediatr Res 1994, 36:755-762.
87. Robillard J.E., Weismann D.N., Gomez R.A., Ayres N.A., Lawton W.J., van Orden D.E. Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life. Am J Physiol 1983, 244:R249-R256.
88. Saavedra J.M., Viswanathan M., Shigematsu K. Localization of angiotensin AT1 receptors in the rat heart conduction system. Eur J Pharmacol 1993, 235:301-303.
89. Samyn M.E., Petershack J.A., Bedell K.A., Mathews M.S., Segar J.L. Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep. Pediatr Res 1998, 44:323-329.
90. Schieffer B., Paxton W.G., Marrero M.B., Bernstein K.E. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling. Hypertension 1996, 27:476-480.
91. Schutz S., Le Moullec J.M., Corvol P., Gasc J.M. Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996, 149:2067-2079.
92. Scott A.A., Purohit D.M. Neonatal renal failure: a complication of maternal antihypertensive therapy. Am J Obstet Gynecol 1989, 160:1223-1224.
93. Scott A.L., Chang R.S.L., Lotti V.J., Siegl P.K. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DuP 753 and PD 121981, in rabbit heart. J Pharmacol Exp Ther 1992, 261:931-935.
94. Sechi L.A., Grady E.F., Griffin C.A., Kalinyak J.E., Schambelan M. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177. J Hypertens 1991, 9(6):S224-S225.
95. Sedman A.B., Kershaw D.B., Bunchman T.E. Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol 1995, 9:382-385.
96. Shanmugam S., Corvol P., Gasc J.M. Ontogeny of the two angiotensin II type 1 receptor subtypes in rats. Am J Physiol 1994, 267:E828-E836.
97. Shanmugam S., Corvol P., Gasc J.M. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 1996, 28:91-97.
98. Shanmugam S., Llorens-Cortes C., Clauser E., Corvol P., Gasc J.M. Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol 1995, 268:F922-F930.
99. Shanmugam S., Sandberg K. Ontogeny of angiotensin II receptors. Cell Biol Int 1996, 20:169-176.
100. Siegel S.R., Fisher D.A. The effects of angiotensin II blockade and nephrectomy on the renin-angiotensin-aldosterone system in the newborn lamb. Pediatr Res 1979, 13:603-605.
101. Siragy H.M., Bedigian M. Mechanism of action of angiotensin-receptor blocking agents. Curr Hypertens Rep 1999, 1:289-295.
102. Siragy H.M., Carey R.M. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996, 97:1978-1982.
103. Siragy H.M., Carey R.M. Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2001, 10:99-103.
104. Siragy H.M., El-Kersh M.A., de Gasparo M., Webb R.L., Carey R.M. Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. J Hypertens 2002, 20:1157-1163.
105. Siragy H.M., Inagami T., Ichiki T., Carey R.M. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999, 96:6506-6510.
106. Smith F.G., Chan S., de Wildt S.N. Effects of renal denervation on cardiovascular and renal responses to ACE inhibition in conscious lambs. J Appl Physiol 1997, 83:414-419.
107. Solhaug M.J., Wallace M.R., Granger J.P. The role of angiotensin II in the renal hemodynamics of the developing piglet. J Am Soc Nephrol 1993, 4:587.
108. Solhaug M.J., Wallace M.R., Granger J.P. Nitric oxide and angiotensin II regulation of renal hemodynamics in the developing piglet. Pediatr Res 1996, 39:527-533.
109. Sorensen A.M., Christensen S., Jonassen T.E., Andersen D., Petersen J.S. Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists. Ugeskr Laeger 1998, 160:1460-1464.
110. Stoll M., Unger T. Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept 2001, 99:175-182.
111. Tabacova S., Little R., Tsong Y., Vega A., Kimmel C.A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003, 12:633-646.
112. Tabacova S.A., Kimmel C.A. Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review. Reprod Toxicol 2001, 15:467-478.
113. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993, 45:205-251.
114. Tufro-McReddie A., Romano L.M., Harris J.M., Ferder L., Gomez R.A. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 1995, 269:F110-F115.
115. Unger T., Dahlof B. Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential. J Renin Angiotensin Aldosterone Syst 2010, 11:75-77.
116. Velaphi S.C., Roy T., Despain K., Rosenfeld C.R. Differential responses to systemic and local angiotensin II infusions in conscious postnatal sheep. Pediatr Res 2002, 52:333-341.
117. Vinturache A., Qi W., Smith F.G. Age dependent expression of angiotensin receptors in the developing kidney. FASEB J 2009, 23:606.2.
118. Vinturache A.E., Smith F.G. Angiotensin receptors modulate the renal hemodynamic effects of nitric oxide in conscious newborn lambs. Physiol Rep 2014, 2(5):e12027.
119. Vinturache A.E., Smith F.G. Haemodynamic effects of angiotensin II in conscious lambs during postnatal maturation: role of type 1 and type 2 receptors. J Renin-Angiotensin-Aldosterone Syst 2014, 1-8. 10.1177/1470320313506479.
120. Viswanathan M., Tsutsumi K., Correa F.M., Saavedra J.M. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991, 179:1361-1367.
121. Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?. J Hypertens 2003, 21:1429-1443.
122. Wallace K.B., Hook J.B., Bailie M.D. Postnatal development of the renin-angiotensin system in rats. Am J Physiol 1980, 238:R432-R437.
123. Walters P.E., Gaspari T.A., Widdop R.E. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 2005, 45:960-966.
124. Wehlage S.J., Smith F.G. Nitric oxide and angiotensin II regulate cardiovascular homeostasis and the arterial baroreflex control of heart rate in conscious lambs. J Renin Angiotensin Aldosterone Syst 2012, 13:99-107.
125. Widdop R.E., Jones E.S., Hannan R.E., Gaspari T.A. Angiotensin AT2 receptors: cardiovascular hope or hype?. Br J Pharmacol 2003, 140:809-824.
126. Wilson T.A., Kaiser D.L., Wright E.M., Ortt E.M., Freedlender A.E., Peach M.J., et al. Importance of plasma angiotensin concentrations in a comparative study of responses to angiotensin in the maturing newborn lamb. Hypertension 1981, 3:II-18-II-24.
127. Wilson T.A., Kaiser D.L., Wright E.M., Peach M.J., Carey R.M. Ontogeny of blood pressure and the renin-angiotensin-aldosterone system. Sequential studies in the newborn lamb. Circ Res 1981, 49:416-423.
128. Wintour E.M., Alcorn D., Albiston A., Boon W.C., Butkus A., Earnest L., et al. The renin-angiotensin system and the development of the kidney and adrenal in sheep. Clin Exp Pharmacol Physiol 1998, 25:S97-S100.
129. Wintour E.M., Moritz K., Butkus A., Baird R., Albiston A., Tenis N. Ontogeny and regulation of the AT1 and AT2 receptors in the ovine fetal adrenal gland. Mol Cell Endocrinol 1999, 157:161-170.
130. Wolf G. Angiotensin II and tubular development. Nephrol Dial Transplant 2002, 17:48-51.
131. Woods L.L., Ingelfinger J.R., Nyengaard J.R., Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001, 49:460-467.
132. Yosipiv I.V., El-Dahr S.S. Developmental biology of angiotensin-converting enzyme. Pediatr Nephrol 1998, 12:72-79.
133. Young M. Blood pressure in the new-born baby. Br Med Bull 1961, 17:154-159.
134. Yu L., Zheng M., Wang W., Rozanski G.J., Zucker I.H., Gao L. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst 2010, 11:214-221.
135. Zhuo J., Maric C., Harris P.J., Alcorn D., Mendelsohn F.A. Localization and functional properties of angiotensin II AT1 receptors in the kidney: focus on renomedullary interstitial cells. Hypertens Res 1997, 20:233-250.
136. Zhuo J., Song K., Harris P.J., Mendelsohn F.A.O. Angiotensin II receptor subtypes in rat kidney and adrenal gland. Proc Aust Physiol Pharmacol Soc 1991, 22(2):199P.